Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor cell permeability to peplomycin.

H Kuramochi1, K Takahashi, T Takeuchi

  • 1Research Laboratories, Nippon Kayaku Co., Ltd., Tokyo, Japan.

The Journal of Antibiotics
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer.

European journal of cancer (Oxford, England : 1990)·2019
Same author

Effects of Plant Growth Regulators on Shoot Growth and Flowering of a Perennia Paddy Weed, Sagittaria pygmaea Miq.

Bioscience, biotechnology, and biochemistry·2016
Same author

Enantioselective Herbicidal Activity of Chiral α-Methylbenzylphenylureas against Cyperaceae and Echinochloa Paddy Weeds.

Bioscience, biotechnology, and biochemistry·2016
Same author

Promotion of Flowering in Sagittaria pygmaea Miq. by 2,6-Diisopropylphenoxyacetic Acid.

Bioscience, biotechnology, and biochemistry·2016
Same author

The advantages of the magnetic structure in ferromagnetic-film-coated carbon nanotube probes.

Nanotechnology·2011
Same author

Why nano-oxidation with carbon nanotube probes is so stable: I. Linkage between hydrophobicity and stability.

Nanotechnology·2011
Same journal

Pheophorbide a from Acrotrema agastyamalayanum: A potent antibiofilm agent targeting Proteus mirabilis.

The Journal of antibiotics·2026
Same journal

Tsukubacyclinone, a novel angucyclinone compound with anti-inflammatory activity in synovial cell line SW982, produced by Streptomyces sp. K21-0141.

The Journal of antibiotics·2026
Same journal

Macrolide antibiotic action, resistance, and tolerance, and approaches to improve their activity against Gram-negative bacteria.

The Journal of antibiotics·2026
Same journal

Activation of hamiformamide production in the thermotolerant fungus Hamigera avellanea triggered by co-culture with animal immune cells.

The Journal of antibiotics·2026
Same journal

Biosynthesis and enzymology of azaindane natural products.

The Journal of antibiotics·2026
Same journal

Inhibition of Proteus mirabilis growth through gallium-based disruption of iron and heme metabolism.

The Journal of antibiotics·2026
See all related articles

The study investigated how [3H]peplomycin-Cu(II) ([3H]PEP-Cu(II)) enters tumor cells. Results suggest passive diffusion, influenced by cell membrane properties, rather than a carrier system, is the primary uptake mechanism.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Peplomycin-Cu(II) ([PEP-Cu(II)]) is an anticancer agent with potential therapeutic applications.
  • Understanding the cellular uptake mechanisms of [3H]PEP-Cu(II)] is crucial for optimizing its delivery and efficacy in cancer treatment.

Purpose of the Study:

  • To elucidate the cellular uptake kinetics and mechanisms of [3H]peplomycin-Cu(II) ([3H]PEP-Cu(II)) in various tumor cell lines.
  • To investigate the influence of drug concentration, metabolic state, and membrane fluidity on [3H]PEP-Cu(II)] uptake.

Main Methods:

  • Time-course studies of [3H]PEP-Cu(II)] uptake in AH66, AH66F, Ehrlich, P388, and L1210 tumor cell lines.
  • Analysis of drug metabolism within cells, detecting deamide PEP.
  • Investigation of uptake under conditions of varying drug concentration, metabolic inhibition (NaN3, 2,4-dinitrophenol), and membrane modification (dibucaine, chlorpromazine).

Related Experiment Videos

Main Results:

  • [3H]PEP-Cu(II) uptake exhibited biphasic kinetics in most cell lines, with a rapid initial phase and a slower second phase.
  • Uptake was proportional to extracellular drug concentration, indicating a lack of carrier-mediated transport.
  • Metabolic inhibitors and membrane-fluidizing agents enhanced uptake, suggesting passive diffusion influenced by membrane properties and energy-dependent barriers.
  • Deamide PEP was detected intracellularly, confirming PEP-Cu(II) transport, copper dissociation, and subsequent PEP metabolism.

Conclusions:

  • [3H]PEP-Cu(II) uptake into tumor cells appears to occur primarily via passive diffusion.
  • The cell membrane acts as an energy-dependent barrier modulating the rate of passive diffusion.
  • Cellular uptake and sensitivity to PEP may be linked, but exceptions like AH66F cells suggest complex interactions.